Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms

Geert van Weelden1,2, Marcin Bobiński3, Karolina Okła4

  • 1Faculty of Science, (Medical) Biology, Radboud University, 6525 XZ Nijmegen, The Netherlands. geertvweelden@gmail.com.

Marine Drugs
|January 10, 2019
PubMed

Insights

Fucoidan, a compound from brown algae, shows promise for cancer treatment by influencing key cell pathways. Further research into its structure-activity relationship is needed for optimized anti-cancer applications.

Area of Science:

  • Marine Biotechnology
  • Pharmacology
  • Oncology

Background:

  • Fucoidan, a sulfated polysaccharide from brown algae, exhibits potential anti-cancer properties.
  • The precise mechanisms underlying fucoidan's anti-cancer effects are not fully understood.
  • Variability in fucoidan structure due to species and extraction methods complicates its bioactivity assessment.

Purpose of the Study:

  • To review fucoidan's structure, bioavailability, and affected pathways in relation to its anti-cancer mechanisms.
  • To elucidate the structure-activity relationship of fucoidan for cancer therapy.
  • To explore fucoidan's potential as an adjunct cancer treatment.

Main Methods:

  • Literature review of studies on fucoidan's anti-cancer properties.
  • Analysis of fucoidan's effects on cellular signaling pathways.
  • Investigation of fucoidan's interactions with growth factors and receptors.

Main Results:

  • Fucoidan influences critical cancer-related pathways, including PI3K/AKT, MAPK, and caspase pathways.
  • PTEN plays a role in fucoidan's modulation of the AKT pathway.
  • Fucoidan interacts with VEGF, BMP, TGF-β, and estrogen receptors, and may enhance chemotherapy efficacy while reducing toxicity.

Conclusions:

  • Fucoidan demonstrates multipotent anti-cancer characteristics, offering promise for future therapeutic strategies.
  • Further research is essential to define the structure-activity relationship of fucoidan from specific seaweed species.
  • Optimizing fucoidan extraction and characterization is key to unlocking its full therapeutic potential.

Related Concept Videos

Radical Anti-Markovnikov Addition to Alkenes: Mechanism01:17

Radical Anti-Markovnikov Addition to Alkenes: Mechanism

The reaction of hydrogen bromide with alkenes in the presence of hydroperoxides or peroxides proceeds via anti-Markovnikov addition. The radical chain reaction comprises initiation, propagation, and termination steps.
The mechanism starts with chain initiation, which involves two steps. In the first chain initiation step, a weak peroxide bond is homolytically cleaved upon mild heating to form two alkoxy radicals. In the second initiation step, a hydrogen atom is abstracted by the alkoxy...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.8K